Cognipride MP 2mg/500mg/15mg Tablet SR
Marketer
Cognitive Life Sciences Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Cognipride MP 2mg/500mg/15mg Tablet SR
Diabetic patients with type 2 mellitus can use the extended-release combination medication, Cognipride MP (2mg/500mg/15mg), to manage blood glucose. This treatment, in conjunction with diet and exercise, improves glycemic control by enhancing insulin effectiveness and consequently reducing blood sugar. Adhere strictly to your physician's prescribed dosage and duration; ingest it with food to mitigate gastrointestinal distress. Missed doses should be taken promptly unless the next dose is imminent; never double the dose. An overdose can trigger hypoglycemia (low blood sugar). Concurrent use with other antidiabetic drugs, alcohol consumption, or meal skipping may increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Individuals with pre-existing kidney, liver, or heart conditions, or those pregnant or lactating, must consult their doctor before commencing treatment. Baseline kidney function tests are required prior to therapy initiation. Limit alcohol consumption to reduce the likelihood of side effects.
Uses of Cognipride MP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Cognipride MP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; do not crush, chew, or divide it. Cognipride MP 2mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Cognipride MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Cognipride MP 2mg/500mg/15mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Cognipride MP 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
How Cognipride MP 2mg/500mg/15mg Tablet SR works:
Cognipride MP SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Cognipride MP 2mg/500mg/15mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Using Cognipride MP 2mg/500mg/15mg SR tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Cognipride MP 2mg/500mg/15mg tablet likely poses a risk during lactation. Available human data indicate potential transfer to breast milk, with the possibility of infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Cognipride MP 2mg/500mg/15mg SR tablets, as dose modification may be necessary. Severe kidney disease contraindicates the use of Cognipride MP 2mg/500mg/15mg SR tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Cognipride MP 2mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Cognipride MP 2mg/500mg/15mg Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Cognipride MP 2mg/500mg/15mg Tablet SR :
Should you forget a Cognipride MP 2mg/500mg/15mg Tablet SR dose, take it immediately if feasible. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Cognipride MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently